<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00321464</url>
  </required_header>
  <id_info>
    <org_study_id>20050136</org_study_id>
    <nct_id>NCT00321464</nct_id>
  </id_info>
  <brief_title>A Study Comparing Denosumab vs. Zoledronic Acid for the Treatment of Bone Metastases in Breast Cancer Subjects.</brief_title>
  <official_title>A Randomized, Double-Blind, Multicenter Study of Denosumab Compared With Zoledronic Acid (ZometaÂ®) in the Treatment of Bone Metastases in Subjects With Advanced Breast Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Amgen</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Daiichi Sankyo, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Amgen</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if denosumab is non-inferior to zoledronic acid in
      the treatment of bone metastases in subjects with advanced breast cancer.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2006</start_date>
  <completion_date type="Actual">April 2012</completion_date>
  <primary_completion_date type="Actual">March 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to First On-Study Skeletal Related Event (SRE) (Non-inferiority)</measure>
    <time_frame>Up to 34 months</time_frame>
    <description>Time to first on-study skeletal-related event (SRE) using a non-inferiority analysis. The median time to first skeletal-related event could not be estimated in one treatment arm, so the subject incidence is presented.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to First On-Study Skeletal-Related Event (Superiority)</measure>
    <time_frame>Up to 34 months</time_frame>
    <description>Time to first on-study skeletal-related event (SRE) using a superiority analysis. The median time to first skeletal-related event could not be estimated in one treatment arm, so the subject incidence is presented.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to First and Subsequent On-Study Skeletal-Related Event</measure>
    <time_frame>Up to 34 months</time_frame>
    <description>Time to first and subsequent on-study skeletal-related event (SRE) using a multiple event analysis. To be considered a subsequent SRE, the event must occur at least 21 days after the previous SRE. This outcome measure utilizes multiple event times, was analyzed based on a proportional mean model, and is therefore more appropriately summarized by the cumulative number of events.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">2049</enrollment>
  <condition>Bone Metastases</condition>
  <arm_group>
    <arm_group_label>zoledronic acid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>denosumab</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Denosumab</intervention_name>
    <description>Q4W 120 mg denosumab SC injection and 4 mg zoledronic acid (Zometa) placebo IV over a minimum of 15 minutes</description>
    <arm_group_label>denosumab</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Zoledronic Acid</intervention_name>
    <description>Q4W 4 mg zoledronic acid IV over minimum 15 minutes and 120 mg denosumab placebo SC</description>
    <arm_group_label>zoledronic acid</arm_group_label>
    <other_name>Zometa</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults with histologically or cytologically confirmed breast adenocarcinoma

          -  radiographic evidence of at least one bone mets

          -  Easter Cooperative Oncology Group status of 0, 1 or 2;

          -  adequate organ function

        Exclusion Criteria:

          -  Current or prior IV bisphosphonate administration

          -  current or prior oral bisphosphonates for bone mets

          -  life expectancy of less than 6 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>MD</last_name>
    <role>Study Director</role>
    <affiliation>Amgen</affiliation>
  </overall_official>
  <removed_countries>
    <country>Argentina</country>
    <country>Australia</country>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Brazil</country>
    <country>Bulgaria</country>
    <country>Canada</country>
    <country>Chile</country>
    <country>Czech Republic</country>
    <country>Denmark</country>
    <country>Estonia</country>
    <country>France</country>
    <country>Germany</country>
    <country>Hungary</country>
    <country>India</country>
    <country>Israel</country>
    <country>Italy</country>
    <country>Japan</country>
    <country>Latvia</country>
    <country>Lithuania</country>
    <country>Mexico</country>
    <country>Netherlands</country>
    <country>Panama</country>
    <country>Peru</country>
    <country>Poland</country>
    <country>Romania</country>
    <country>Russian Federation</country>
    <country>Slovakia</country>
    <country>South Africa</country>
    <country>Spain</country>
    <country>Sweden</country>
    <country>Switzerland</country>
    <country>Turkey</country>
    <country>Ukraine</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </removed_countries>
  <link>
    <url>http://www.amgentrials.com</url>
    <description>AmgenTrials clinical trials website</description>
  </link>
  <reference>
    <citation>Stopeck AT, Lipton A, Body JJ, Steger GG, Tonkin K, de Boer RH, Lichinitser M, Fujiwara Y, Yardley DA, Viniegra M, Fan M, Jiang Q, Dansey R, Jun S, Braun A. Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study. J Clin Oncol. 2010 Dec 10;28(35):5132-9. doi: 10.1200/JCO.2010.29.7101. Epub 2010 Nov 8.</citation>
    <PMID>21060033</PMID>
  </reference>
  <reference>
    <citation>Cleeland CS, Body JJ, Stopeck A, von Moos R, Fallowfield L, Mathias SD, Patrick DL, Clemons M, Tonkin K, Masuda N, Lipton A, de Boer R, Salvagni S, Oliveira CT, Qian Y, Jiang Q, Dansey R, Braun A, Chung K. Pain outcomes in patients with advanced breast cancer and bone metastases: results from a randomized, double-blind study of denosumab and zoledronic acid. Cancer. 2013 Feb 15;119(4):832-8. doi: 10.1002/cncr.27789. Epub 2012 Sep 5.</citation>
    <PMID>22951813</PMID>
  </reference>
  <reference>
    <citation>Martin M, Bell R, Bourgeois H, Brufsky A, Diel I, Eniu A, Fallowfield L, Fujiwara Y, Jassem J, Paterson AH, Ritchie D, Steger GG, Stopeck A, Vogel C, Fan M, Jiang Q, Chung K, Dansey R, Braun A. Bone-related complications and quality of life in advanced breast cancer: results from a randomized phase III trial of denosumab versus zoledronic acid. Clin Cancer Res. 2012 Sep 1;18(17):4841-9. Epub 2012 Aug 14.</citation>
    <PMID>22893628</PMID>
  </reference>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 2, 2006</study_first_submitted>
  <study_first_submitted_qc>May 2, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 3, 2006</study_first_posted>
  <results_first_submitted>December 10, 2010</results_first_submitted>
  <results_first_submitted_qc>January 23, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">March 10, 2014</results_first_posted>
  <disposition_first_submitted>June 29, 2010</disposition_first_submitted>
  <disposition_first_submitted_qc>June 29, 2010</disposition_first_submitted_qc>
  <disposition_first_posted type="Estimate">July 1, 2010</disposition_first_posted>
  <last_update_submitted>January 25, 2017</last_update_submitted>
  <last_update_submitted_qc>January 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Fractures</keyword>
  <keyword>Compressions</keyword>
  <keyword>Bisphosphonates</keyword>
  <keyword>Bone metastases</keyword>
  <keyword>Breast cancer</keyword>
  <keyword>Skeletal</keyword>
  <keyword>Radiation</keyword>
  <keyword>Surgery to Bone</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
    <mesh_term>Neoplasm Metastasis</mesh_term>
    <mesh_term>Neoplasms, Second Primary</mesh_term>
    <mesh_term>Bone Neoplasms</mesh_term>
    <mesh_term>Bone Marrow Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Zoledronic acid</mesh_term>
    <mesh_term>Diphosphonates</mesh_term>
    <mesh_term>Denosumab</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants were enrolled from 27 April 2006 through 31 December 2007</recruitment_details>
      <pre_assignment_details>2049 patients were enrolled in the study, but 3 patients were excluded from all analyses because properly documented informed consent was not obtained.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Zoledronic Acid</title>
          <description>Zoledronic acid 4 mg by intravenous injection with subcutaneous denosumab placebo once every 4 weeks</description>
        </group>
        <group group_id="P2">
          <title>Denosumab</title>
          <description>Denomsumab 120 mg subcutaneously with intravenous zoledronic acid placebo once every 4 weeks</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="1020"/>
                <participants group_id="P2" count="1026"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Received Investigational Product</title>
              <participants_list>
                <participants group_id="P1" count="1014"/>
                <participants group_id="P2" count="1019"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="461"/>
                <participants group_id="P2" count="468"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="559"/>
                <participants group_id="P2" count="558"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="169"/>
                <participants group_id="P2" count="174"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Disease progression</title>
              <participants_list>
                <participants group_id="P1" count="124"/>
                <participants group_id="P2" count="124"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="117"/>
                <participants group_id="P2" count="118"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Participant request</title>
              <participants_list>
                <participants group_id="P1" count="57"/>
                <participants group_id="P2" count="61"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="43"/>
                <participants group_id="P2" count="28"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="14"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Noncompliance</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="8"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol deviation</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Ineligibility determined</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="18"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Zoledronic Acid</title>
          <description>Zoledronic acid 4 mg by intravenous injection with subcutaneous denosumab placebo once every 4 weeks</description>
        </group>
        <group group_id="B2">
          <title>Denosumab</title>
          <description>Denomsumab 120 mg subcutaneously with intravenous zoledronic acid placebo once every 4 weeks</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="1020"/>
            <count group_id="B2" value="1026"/>
            <count group_id="B3" value="2046"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="56.6" spread="11.6"/>
                    <measurement group_id="B2" value="56.8" spread="11.5"/>
                    <measurement group_id="B3" value="56.7" spread="11.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1011"/>
                    <measurement group_id="B2" value="1018"/>
                    <measurement group_id="B3" value="2029"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>White or Caucasian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="813"/>
                    <measurement group_id="B2" value="822"/>
                    <measurement group_id="B3" value="1635"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="59"/>
                    <measurement group_id="B2" value="59"/>
                    <measurement group_id="B3" value="118"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37"/>
                    <measurement group_id="B2" value="32"/>
                    <measurement group_id="B3" value="69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Japanese</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="69"/>
                    <measurement group_id="B2" value="70"/>
                    <measurement group_id="B3" value="139"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian or Other Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Previous Skeletal-Related Event Stratification Factor</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="373"/>
                    <measurement group_id="B2" value="378"/>
                    <measurement group_id="B3" value="751"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="647"/>
                    <measurement group_id="B2" value="648"/>
                    <measurement group_id="B3" value="1295"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Prior Oral Bisphosphonate Use Stratification Factor</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38"/>
                    <measurement group_id="B2" value="42"/>
                    <measurement group_id="B3" value="80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="982"/>
                    <measurement group_id="B2" value="984"/>
                    <measurement group_id="B3" value="1966"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Current Chemotherapy Stratification Factor</title>
          <description>Defined as within 6 weeks before randomization</description>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="408"/>
                    <measurement group_id="B2" value="410"/>
                    <measurement group_id="B3" value="818"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="612"/>
                    <measurement group_id="B2" value="616"/>
                    <measurement group_id="B3" value="1228"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Japan Stratification Factor</title>
          <description>Participant located in Japan</description>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="67"/>
                    <measurement group_id="B2" value="69"/>
                    <measurement group_id="B3" value="136"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="953"/>
                    <measurement group_id="B2" value="957"/>
                    <measurement group_id="B3" value="1910"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Time to First On-Study Skeletal Related Event (SRE) (Non-inferiority)</title>
        <description>Time to first on-study skeletal-related event (SRE) using a non-inferiority analysis. The median time to first skeletal-related event could not be estimated in one treatment arm, so the subject incidence is presented.</description>
        <time_frame>Up to 34 months</time_frame>
        <population>Full Analysis Set, composed of all randomized participants.</population>
        <group_list>
          <group group_id="O1">
            <title>Zoledronic Acid</title>
            <description>Zoledronic acid 4 mg by intravenous injection with subcutaneous denosumab placebo once every 4 weeks</description>
          </group>
          <group group_id="O2">
            <title>Denosumab</title>
            <description>Denomsumab 120 mg subcutaneously with intravenous zoledronic acid placebo once every 4 weeks</description>
          </group>
        </group_list>
        <measure>
          <title>Time to First On-Study Skeletal Related Event (SRE) (Non-inferiority)</title>
          <description>Time to first on-study skeletal-related event (SRE) using a non-inferiority analysis. The median time to first skeletal-related event could not be estimated in one treatment arm, so the subject incidence is presented.</description>
          <population>Full Analysis Set, composed of all randomized participants.</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1020"/>
                <count group_id="O2" value="1026"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="372"/>
                    <measurement group_id="O2" value="315"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>A synthesis method was used for the non-inferiority test for the hypothesis that denosumab preserves at least 50% of the effect of zoledronic acid vs. placebo.</non_inferiority_desc>
            <p_value>&lt;0.0001</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.82</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.71</ci_lower_limit>
            <ci_upper_limit>0.95</ci_upper_limit>
            <estimate_desc>Stratified by the randomization stratification factors (previous skeletal-related event, prior oral bisphosphonate use, current chemotherapy, and location in Japan).</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to First On-Study Skeletal-Related Event (Superiority)</title>
        <description>Time to first on-study skeletal-related event (SRE) using a superiority analysis. The median time to first skeletal-related event could not be estimated in one treatment arm, so the subject incidence is presented.</description>
        <time_frame>Up to 34 months</time_frame>
        <population>Full Analysis Set, composed of all randomized participants.</population>
        <group_list>
          <group group_id="O1">
            <title>Zoledronic Acid</title>
            <description>Zoledronic acid 4 mg by intravenous injection with subcutaneous denosumab placebo once every 4 weeks</description>
          </group>
          <group group_id="O2">
            <title>Denosumab</title>
            <description>Denomsumab 120 mg subcutaneously with intravenous zoledronic acid placebo once every 4 weeks</description>
          </group>
        </group_list>
        <measure>
          <title>Time to First On-Study Skeletal-Related Event (Superiority)</title>
          <description>Time to first on-study skeletal-related event (SRE) using a superiority analysis. The median time to first skeletal-related event could not be estimated in one treatment arm, so the subject incidence is presented.</description>
          <population>Full Analysis Set, composed of all randomized participants.</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1020"/>
                <count group_id="O2" value="1026"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="372"/>
                    <measurement group_id="O2" value="315"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.010</p_value>
            <p_value_desc>P-value was adjusted for multiplicity according to a hierarchical testing strategy and Hochberg procedure</p_value_desc>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.82</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.71</ci_lower_limit>
            <ci_upper_limit>0.95</ci_upper_limit>
            <estimate_desc>Stratified by the randomization stratification factors (previous skeletal-related event, prior oral bisphosphonate use, current chemotherapy, and location in Japan).</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to First and Subsequent On-Study Skeletal-Related Event</title>
        <description>Time to first and subsequent on-study skeletal-related event (SRE) using a multiple event analysis. To be considered a subsequent SRE, the event must occur at least 21 days after the previous SRE. This outcome measure utilizes multiple event times, was analyzed based on a proportional mean model, and is therefore more appropriately summarized by the cumulative number of events.</description>
        <time_frame>Up to 34 months</time_frame>
        <population>Full Analysis Set, composed of all randomized participants</population>
        <group_list>
          <group group_id="O1">
            <title>Zoledronic Acid</title>
            <description>Zoledronic acid 4 mg by intravenous injection with subcutaneous denosumab placebo once every 4 weeks</description>
          </group>
          <group group_id="O2">
            <title>Denosumab</title>
            <description>Denomsumab 120 mg subcutaneously with intravenous zoledronic acid placebo once every 4 weeks</description>
          </group>
        </group_list>
        <measure>
          <title>Time to First and Subsequent On-Study Skeletal-Related Event</title>
          <description>Time to first and subsequent on-study skeletal-related event (SRE) using a multiple event analysis. To be considered a subsequent SRE, the event must occur at least 21 days after the previous SRE. This outcome measure utilizes multiple event times, was analyzed based on a proportional mean model, and is therefore more appropriately summarized by the cumulative number of events.</description>
          <population>Full Analysis Set, composed of all randomized participants</population>
          <units>Events</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1020"/>
                <count group_id="O2" value="1026"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="608"/>
                    <measurement group_id="O2" value="474"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.001</p_value>
            <p_value_desc>P-value was adjusted for multiplicity according to a hierarchical testing strategy and Hochberg procedure</p_value_desc>
            <method>Anderson-Gill model</method>
            <param_type>Rate ratio</param_type>
            <param_value>0.77</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.66</ci_lower_limit>
            <ci_upper_limit>0.89</ci_upper_limit>
            <estimate_desc>Stratified by the randomization stratification factors (previous skeletal-related event, prior oral bisphosphonate use, current chemotherapy, and location in Japan).</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>up to 2 years 10 months</time_frame>
      <desc>The table of Other Adverse Events summarizes the most frequent non-serious occurrences of adverse events.
One subject who was randomized to zoledronic acid and received denosumab as the 1st investigational product was analyzed on the denosumab arm for safety analyses.</desc>
      <group_list>
        <group group_id="E1">
          <title>Zoledronic Acid 4 mg Q4W</title>
        </group>
        <group group_id="E2">
          <title>Denosumab 120 mg Q4W</title>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 12.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="471" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="453" subjects_at_risk="1020"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="32" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="27" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Bone marrow failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Coagulopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Disseminated intravascular coagulation</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Febrile neutropenia</sub_title>
                <counts group_id="E1" subjects_affected="22" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Haemolytic anaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Heparin-induced thrombocytopenia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Leukopenia</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Lymphadenitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Lymphadenopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Neutropenia</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Pancytopenia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Platelet disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="1020"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Acute coronary syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Acute myocardial infarction</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Angina unstable</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Arrhythmia supraventricular</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Arteriospasm coronary</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Atrioventricular block second degree</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Cardiac failure</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Cardiac failure acute</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Cardiac failure congestive</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Cardiac tamponade</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Cardio-respiratory arrest</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Cardiogenic shock</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Cardiopulmonary failure</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Cardiovascular disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Cytotoxic cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Left ventricular failure</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Palpitations</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Pericardial effusion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Pericarditis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Sinus bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Sinus tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Supraventricular tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Deafness neurosensory</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Meniere's disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1020"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Endocrine disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Amaurosis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Diplopia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Exophthalmos</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Keratitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Macular oedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Optic ischaemic neuropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Photophobia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Ulcerative keratitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Vision blurred</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Visual acuity reduced</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Visual impairment</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal discomfort</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Abdominal distension</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Ascites</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Caecitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Crohn's disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Diarrhoea haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Diverticular perforation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Enteritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Enterocele</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Epigastric discomfort</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Faeces discoloured</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Femoral hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Gastric disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Gastric perforation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Gastric ulcer haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Gastritis erosive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Gastrointestinal inflammation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Gastrointestinal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Haematemesis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Haemorrhoids</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Ileus</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Intestinal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Intestinal perforation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Large intestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Large intestine perforation</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Melaena</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="23" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Neutropenic colitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Odynophagia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Oesophagitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Peritonitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Rectal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Small intestinal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Stomatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Subileus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="31" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="31" subjects_at_risk="1020"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Adverse drug reaction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Catheter site pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Chest discomfort</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Chills</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Condition aggravated</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Crepitations</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Disease progression</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Drowning</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Face oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Gait disturbance</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>General physical health deterioration</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="20" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Generalised oedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Impaired healing</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Implant expulsion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Localised oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Malaise</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Mucosal inflammation</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Multi-organ failure</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Oedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Organ failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Performance status decreased</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="26" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Sudden death</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Systemic inflammatory response syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Acute hepatic failure</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Bile duct obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Cholangitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Cholecystitis acute</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Cholestasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Hepatic congestion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Hepatic cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Hepatic failure</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="24" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Hepatic function abnormal</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Hepatic haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Hepatitis acute</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Hepatitis toxic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Hepatorenal failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Hepatotoxicity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Hyperbilirubinaemia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Jaundice</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Liver disorder</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaphylactic reaction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Anaphylactic shock</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Drug hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abdominal abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Abdominal infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Abdominal wall abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Abdominal wall infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Abscess jaw</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Abscess limb</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Abscess neck</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Anal abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Bacteraemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Bacterial sepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Breast cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Candida sepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Catheter related infection</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Catheter sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Clostridial infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Cystitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Diabetic foot infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Ear infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Endocarditis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Erysipelas</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Escherichia bacteraemia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Escherichia sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Gastrointestinal infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Herpes zoster</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Klebsiella sepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Lobar pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Localised infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Lower respiratory tract infection bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Lung infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Mastitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Meningitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Neutropenic infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Neutropenic sepsis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Oral fungal infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Osteomyelitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Periodontal infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Peritoneal abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="25" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="20" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Pneumonia primary atypical</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Postoperative wound infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Pseudomonal bacteraemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Pseudomonal sepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Pyelonephritis chronic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Salmonellosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Septic shock</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Staphylococcal bacteraemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Staphylococcal sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Stenotrophomonas sepsis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Streptococcal bacteraemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Streptococcal sepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Subcutaneous abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Tonsillitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Urinary tract infection bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Viral infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Wound infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Arthropod bite</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Concussion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Drug toxicity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Femur fracture</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Fibula fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Fracture</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Gastroenteritis radiation</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Head injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Humerus fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Incorrect route of drug administration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Ligament rupture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Lumbar vertebral fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Medical device complication</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Medication error</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Patella fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Poisoning</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Post-traumatic pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Radiation injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Radiation myelopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Radius fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Recall phenomenon</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Rib fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Skin laceration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Subdural haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Subdural haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Tendon rupture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Thermal burn</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Thoracic vertebral fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Tibia fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Tracheal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Ulna fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Wound dehiscence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Alanine aminotransferase increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Aspartate aminotransferase increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Aspiration bronchial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Blood alkaline phosphatase increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Blood bilirubin increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Blood culture positive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Blood glucose increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Blood lactate dehydrogenase increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Blood pressure increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Blood urea increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>C-reactive protein increased</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Electrocardiogram QT prolonged</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Gamma-glutamyltransferase increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Haemoglobin decreased</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Hepatic enzyme increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>International normalised ratio increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Liver function test abnormal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Platelet count decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Renal function test abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Weight decreased</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>White blood cell count abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Acidosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Anorexia</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Cachexia</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Decreased appetite</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="24" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus inadequate control</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Diabetic foot</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Electrolyte imbalance</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Failure to thrive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Fluid overload</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Hypercalcaemia</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Hypocalcaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Hypophagia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Hypophosphataemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Hypovolaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Ketoacidosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Metabolic acidosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Metabolic disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Type 2 diabetes mellitus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Bone pain</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Fistula</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Intervertebral disc protrusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Jaw cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Lumbar spinal stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Muscle spasms</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Muscular weakness</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Myopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Neck pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Osteolysis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Osteonecrosis</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Pain in jaw</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Pathological fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Acute lymphocytic leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Breast cancer</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Breast cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Cancer pain</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Chronic myeloid leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Colon cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Contralateral breast cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Endometrial cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Gastric cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Lipoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Lymphangiosis carcinomatosa</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Malignant ascites</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Malignant neoplasm progression</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Malignant pleural effusion</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Meningioma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Metastases to abdominal cavity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Metastases to biliary tract</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Metastases to bladder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Metastases to bone</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Metastases to bone marrow</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Metastases to central nervous system</sub_title>
                <counts group_id="E1" subjects_affected="46" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="47" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Metastases to eye</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Metastases to gastrointestinal tract</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Metastases to liver</sub_title>
                <counts group_id="E1" subjects_affected="28" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="20" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Metastases to lung</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Metastases to lymph nodes</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Metastases to meninges</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Metastases to ovary</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Metastases to peritoneum</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Metastases to pleura</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Metastases to skin</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Metastases to spine</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Metastases to uterus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Metastasis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Metastatic malignant melanoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Myelofibrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Neoplasm progression</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Paraneoplastic dermatomyositis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Pericarditis malignant</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Rectal cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Tumour associated fever</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Tumour haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Tumour pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Aphasia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Aphonia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Ataxia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Balance disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Brain compression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Brain oedema</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Cerebral haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Cerebral infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Cerebral ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Cerebrovascular disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Cervical cord compression</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Cognitive disorder</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Coma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Convulsion</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Cranial nerve paralysis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Dementia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Depressed level of consciousness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Diplegia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Dysarthria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Epilepsy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Facial palsy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Facial paresis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Haemorrhage intracranial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Haemorrhagic stroke</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Hemiparesis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Hemiplegia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Hepatic encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Hydrocephalus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Hypoaesthesia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Intracranial pressure increased</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Intraventricular haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Ischaemic stroke</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Lethargy</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Leukoencephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Loss of consciousness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Meningism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Migraine</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Monoparesis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Nervous system disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Neurological symptom</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Partial seizures</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Peripheral motor neuropathy</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Phrenic nerve paralysis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Reversible posterior leukoencephalopathy syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Sciatica</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Sensory loss</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Somnolence</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Speech disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Spinal cord compression</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Stupor</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Transient ischaemic attack</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Tremor</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Vascular encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Abnormal behaviour</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Adjustment disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Confusional state</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Disorientation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Mental disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Mental status changes</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Anuria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Calculus urinary</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Hydronephrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Renal colic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Renal failure acute</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Renal pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Urinary hesitation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Urinary retention</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Breast pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Cystocele</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Endometrial hyperplasia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Female genital tract fistula</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Ovarian cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Ovarian mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Pelvic pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Rectocele</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Urogenital prolapse</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Vaginal prolapse</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute pulmonary oedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Acute respiratory distress syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Acute respiratory failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Aspiration</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Atelectasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Bronchitis chronic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Bronchospasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Chronic obstructive pulmonary disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="38" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="53" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Emphysema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Hydropneumothorax</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Hydrothorax</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Interstitial lung disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Lung disorder</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Lung infiltration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Oropharyngeal pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Orthopnoea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Pharyngeal inflammation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" subjects_affected="25" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="24" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Pleurisy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Pleuritic pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Pneumonitis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Pulmonary artery thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Pulmonary hilum mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Pulmonary hypertension</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Pulmonary oedema</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Respiratory arrest</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Respiratory depression</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Respiratory distress</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="20" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Tachypnoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Dermatomyositis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Drug eruption</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Eczema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Exfoliative rash</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Intertrigo</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Pruritus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Rash erythematous</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Skin lesion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Skin ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Abdominal cavity drainage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Arterial bypass operation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Breast reconstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Colostomy closure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Mastectomy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Oophorectomy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Pleurodesis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Radical hysterectomy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Salpingo-oophorectomy bilateral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Simple mastectomy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Skin neoplasm excision</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Cardiovascular insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Circulatory collapse</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Embolism</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Endocrine hypertension</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Flushing</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Haemodynamic instability</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Hypertensive crisis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Hypovolaemic shock</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Iliac artery occlusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Jugular vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Lymphangiopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Peripheral arterial occlusive disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Peripheral ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Phlebitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Subclavian vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Thrombophlebitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Venous thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1020"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA 12.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="941" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="924" subjects_at_risk="1020"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="217" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="183" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Leukopenia</sub_title>
                <counts group_id="E1" subjects_affected="72" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="78" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Neutropenia</sub_title>
                <counts group_id="E1" subjects_affected="118" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="114" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" subjects_affected="53" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="62" subjects_at_risk="1020"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="113" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="114" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" subjects_affected="80" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="68" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="203" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="175" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="198" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="223" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" subjects_affected="73" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="52" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="377" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="350" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Stomatitis</sub_title>
                <counts group_id="E1" subjects_affected="70" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="90" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Toothache</sub_title>
                <counts group_id="E1" subjects_affected="37" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="57" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="225" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="199" subjects_at_risk="1020"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" subjects_affected="192" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="187" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="79" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="90" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Chills</sub_title>
                <counts group_id="E1" subjects_affected="56" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="26" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="323" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="291" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Mucosal inflammation</sub_title>
                <counts group_id="E1" subjects_affected="60" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="68" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" subjects_affected="146" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="172" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" subjects_affected="91" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="68" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="231" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="157" subjects_at_risk="1020"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="54" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="57" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="94" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="83" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="58" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="55" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="86" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="68" subjects_at_risk="1020"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Lumbar vertebral fracture</sub_title>
                <counts group_id="E1" subjects_affected="54" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="35" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Rib fracture</sub_title>
                <counts group_id="E1" subjects_affected="93" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="82" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Thoracic vertebral fracture</sub_title>
                <counts group_id="E1" subjects_affected="76" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="63" subjects_at_risk="1020"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Aspartate aminotransferase increased</sub_title>
                <counts group_id="E1" subjects_affected="53" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="35" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Weight decreased</sub_title>
                <counts group_id="E1" subjects_affected="92" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="78" subjects_at_risk="1020"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Anorexia</sub_title>
                <counts group_id="E1" subjects_affected="171" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="176" subjects_at_risk="1020"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="289" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="246" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="256" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="238" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Bone pain</sub_title>
                <counts group_id="E1" subjects_affected="233" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="181" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" subjects_affected="77" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="81" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" subjects_affected="147" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="147" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" subjects_affected="106" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="82" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Neck pain</sub_title>
                <counts group_id="E1" subjects_affected="71" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="64" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" subjects_affected="221" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="199" subjects_at_risk="1020"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="110" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="102" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="210" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="193" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Neuropathy peripheral</sub_title>
                <counts group_id="E1" subjects_affected="71" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="71" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" subjects_affected="72" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="68" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Peripheral sensory neuropathy</sub_title>
                <counts group_id="E1" subjects_affected="51" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="50" subjects_at_risk="1020"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" subjects_affected="73" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="74" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="85" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="71" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" subjects_affected="136" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="123" subjects_at_risk="1020"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="179" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="171" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="173" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="197" subjects_at_risk="1020"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Alopecia</sub_title>
                <counts group_id="E1" subjects_affected="142" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="159" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Palmar-plantar erythrodysaesthesia syndrome</sub_title>
                <counts group_id="E1" subjects_affected="91" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="91" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Pruritus</sub_title>
                <counts group_id="E1" subjects_affected="66" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="57" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" subjects_affected="99" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="96" subjects_at_risk="1020"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hot flush</sub_title>
                <counts group_id="E1" subjects_affected="70" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="66" subjects_at_risk="1020"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="64" subjects_at_risk="1013"/>
                <counts group_id="E2" subjects_affected="64" subjects_at_risk="1020"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Study Director</name_or_title>
      <organization>Amgen Inc.</organization>
      <phone>866-572-6436</phone>
    </point_of_contact>
  </clinical_results>
</clinical_study>

